Supporting our suppositions about sarcoma stem-like cells’ existence, flow cytometry analysis revealed that the proportion of CD184+, CD271+, CD344+, or CD133+ SHP2E76K MSCs was significantly higher than that of WT MSCs (Figure 2, E–L). The gene discussed is FZD4; the disease is sarcoma.